Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENRICH: Efaproxiral with WBRT for Brain Metastases from Breast Cancer
NCT00083304Phase 3Completed
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Feb 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of efaproxiral in brain metastases, sponsored by Spectrum Pharmaceuticals, Inc.. Started Feb 2004; status: completed.
02
Drugs
efaproxiral
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00083304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083304.